TRCT
SIOX

Tower Research Capital (TRC)’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Tower Research Capital (TRC)’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,453
Closed -$7K – 6639
2022
Q4 		$7K Sell
15,453
-22,853
-60% -$7.42K ﹤0.01% 4666
2022
Q3 		$11K Buy
38,306
+3,292
+9% +$1.13K ﹤0.01% 4497
2022
Q2 		$13K Buy
35,014
+26,752
+324% +$11.1K ﹤0.01% 4255
2022
Q1 		$6K Sell
8,262
-3,811
-32% -$3.24K ﹤0.01% 4980
2021
Q4 		$16K Buy
12,073
+2,811
+30% +$4.99K ﹤0.01% 3959
2021
Q3 		$20K Buy
9,262
+9,161
+9,070% +$19.9K ﹤0.01% 3737
2021
Q2 		$0 Sell
101
-3,978
-98% -$9.89K ﹤0.01% 6044
2021
Q1 		$11K Sell
4,079
-14,227
-78% -$40.2K ﹤0.01% 4337
2020
Q4 		$51K Buy
18,306
+18,291
+121,940% +$53.3K ﹤0.01% 3115
2020
Q3 		$0 Sell
15
-850
-98% -$2.81K ﹤0.01% 5213
2020
Q2 		$2K Buy
865
+399
+86% +$1.28K ﹤0.01% 4556
2020
Q1 		$1K Sell
466
-4,937
-91% -$17.8K ﹤0.01% 2890
2019
Q4 		$28K Buy
5,403
+2,166
+67% +$12K ﹤0.01% 1722
2019
Q3 		$20K Sell
3,237
-984
-23% -$6.79K ﹤0.01% 2488
2019
Q2 		$27K Buy
4,221
+4,171
+8,342% +$31.8K ﹤0.01% 1981
2019
Q1 		$1K Sell
50
-432
-90% -$4.3K ﹤0.01% 3665
2018
Q4 		$4K Sell
482
-1,038
-68% -$15K ﹤0.01% 3099
2018
Q3 		$29K Sell
1,520
-6,247
-80% -$114K ﹤0.01% 2107
2018
Q2 		$141K Buy
7,767
+7,317
+1,626% +$108K 0.01% 1232
2018
Q1 		$4K Buy
450
+390
+650% +$6.26K ﹤0.01% 2819
2017
Q4 		$3K Sell
60
-138
-70% -$6.19K ﹤0.01% 3132
2017
Q3 		$11K Buy
+198
New +$33.4K ﹤0.01% 3043
2017
Q1 		– Sell
-19
Closed -$2K – 4145
2016
Q4 		$2K Sell
19
-559
-97% -$58.9K ﹤0.01% 3496
2016
Q3 		$65K Buy
578
+553
+2,212% +$66.4K 0.01% 1008
2016
Q2 		$3K Buy
25
+10
+67% +$1K ﹤0.01% 3768
2016
Q1 		$1K Sell
15
-121
-89% -$12.9K ﹤0.01% 3851
2015
Q4 		$20K Buy
136
+27
+25% +$3.51K ﹤0.01% 1311
2015
Q3 		$11K Buy
109
+45
+70% +$5.28K ﹤0.01% 2261
2015
Q2 		$10K Buy
+64
New +$10.8K ﹤0.01% 2727

Other funds holding SIOX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Tower Research Capital (TRC)'s SIOX Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 15,453 shares — an estimated $7K sold.

Tower Research Capital (TRC) first reported a position in SIOX in Q2 2015 and held it in 29 quarters. The position peaked at $141K in Q2 2018. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • Tower Research Capital (TRC) reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 15,453 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $7K.
  • Tower Research Capital (TRC) first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and held it in 29 quarters.
  • Tower Research Capital (TRC)'s Sio Gene Therapies Inc. Common Stock position peaked at $141K in Q2 2018.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.